CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 233,197 Value ($000) $10,855 Avg Close $44.52 Range $38.81 - $50.98

Q3 2025

Shares 14,045 Value ($000) $585 Avg Close $31.97 Range $25.83 - $47.41

Q3 2024

Shares 53,042 Value ($000) $2,710 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 114,637 Value ($000) $5,135 Avg Close $46.18 Range $41.01 - $53.70

Q2 2023

Shares 29,089 Value ($000) $524 Avg Close $19.94 Range $15.50 - $24.58

Q4 2022

Shares 744 Value ($000) $14 Avg Close $17.62 Range $15.37 - $19.97

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	233,197	$10,855	$44.52	$38.81 - $50.98
Q3 2025	14,045	$585	$31.97	$25.83 - $47.41
Q3 2024	53,042	$2,710	$51.57	$43.71 - $55.78
Q2 2024	114,637	$5,135	$46.18	$41.01 - $53.70
Q2 2023	29,089	$524	$19.94	$15.50 - $24.58
Q4 2022	744	$14	$17.62	$15.37 - $19.97